Deutsche Bank
DMAC icon

Deutsche Bank’s DiaMedica Therapeutics DMAC Stock Holding History

Deutsche Bank’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Buy
36,323
+7,969
+28% +$49K ﹤0.01% 3125
2026
Q1 		$192K Buy
28,354
+3,988
+16% +$31.6K ﹤0.01% 3020
2025
Q4 		$194K Sell
24,366
-8,401
-26% -$62.8K ﹤0.01% 3024
2025
Q3 		$225K Buy
+32,767
New +$178K ﹤0.01% 3009
2020
Q2 		– Sell
-551
Closed -$2K – 4289
2020
Q1 		$2K Buy
551
+534
+3,141% +$2.21K ﹤0.01% 4210
2019
Q4 		$0 Buy
+17
New +$53 ﹤0.01% 5010

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Deutsche Bank's DMAC Position: Q2 2026 in Review

Deutsche Bank increased its DiaMedica Therapeutics (DMAC) stake by 28% in Q2 2026, buying an estimated $49K and bringing the position to 36,323 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #3125.

Deutsche Bank first reported a position in DMAC in Q4 2019 and has held it in 6 quarters since. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Deutsche Bank held 36,323 shares of DiaMedica Therapeutics worth $256K as of Q2 2026.
  • Deutsche Bank bought 7,969 DiaMedica Therapeutics shares in Q2 2026, an estimated $49K.
  • DiaMedica Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3125 holding.
  • Deutsche Bank first reported a position in DiaMedica Therapeutics in Q4 2019 and has held it in 6 quarters since.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.